We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Benjamin Scirica

Benjamin Morgan Scirica MD

Cardiologist and Director, Innovation, Cardiovascular Division, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School; Senior Investigator, TIMI Study Group, Boston, Massachusetts

Biographical Sketch:

Dr. Benjamin Scirica graduated from Harvard Medical School and trained in internal medicine and cardiovascular medicine at Brigham and Women's Hospital in Boston, Massachusetts. He has a MPH health degree from Harvard School of Public Health. He is currently a Senior Investigator at the TIMI Study Group (an academic research organization based at Brigham and Women's Hospital that has performed over 70 clinical trials in atherosclerotic heart disease), an attending cardiologist and Director of Innovation at the cardiovascular division at Brigham and Women's Hospital, and an associate professor of medicine at Harvard Medical School.

His research interests center on the risk stratification, management, and CV risk reduction of patients with acute coronary syndromes and cardiometabolic disorders. He is the Director of the TIMI ECG Core Laboratory, which has analyzed over 20,000 continuous and static ECGs from multiple trials in acute coronary syndromes, including the ExTRACT-TIMI 25, CLARITY-TIMI 28, DISPERSE-2, PLATO, and MERLIN-TIMI 36 trials. He was principal investigator or co-investigator of the MERLIN-TIMI 36, AVANT GARDE-TIMI 43, TRA 2Pº-TIMI 50, SAVOR-TIMI 53, and CAMELLIA-TIMI 58 trials.

Dr. Scirica has authored or co-authored over 150 peer-reviewed articles, serves on the editorial board of ACCEL, and is a reviewer for multiple journals, including New England Journal, JAMA, The Lancet, Circulation, and Journal of the American College of Cardiology (JACC). He attend in the cardiac intensive care unit at Brigham and Women’s Hospital.

Positions:

Attending Cardiologist and Director, Innovation, Cardiovascular Division, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School; Senior Investigator, TIMI Study Group, Boston, Massachusetts

Degrees:

MD: Harvard Medical School

MPH: Harvard School of Public Health

Postgraduate Training:

Fellowship (internal medicine and cardiovascular medicine): Brigham and Women's Hospital, Boston, Massachusetts

Research Interests:

Identification and application of novel cardiac biomarkers and electrocardiographic techniques

Disclosures

Dr. Scirica reports institutional research grants to Brigham and Women’s Hospital from AstraZeneca, Eisai, Merck, Novartis, NovoNordisk, and Pfizer. Consulting fees from AbbVie, Allergan, AstraZeneca, Boehringer Ingelheim, Eisai, Elsevier Practice Update Cardiology, Esperion, Hamni, Lexicon, Medtronic, Merck, NovoNordisk, and equity in Health [at] Scale.